466 (PB-099) - Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment

C Suppan; I Brcic; E Heitzer; V Tiran; H.D Mueller; M Auer; R.J Cote; R Datar; N Dandachi; M Balic

doi:10.1016/S0959-8049(18)30632-4

$466 (PB-099) - Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment$

Journal article

Peer reviewed

466 (PB-099) - Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment

C Suppan, I Brcic, E Heitzer, V Tiran, H.D Mueller, M Auer, R.J Cote, R Datar, N Dandachi and M Balic

European journal of cancer (1990), Vol.92, pp.S136-S136

2018-04

DOI: https://doi.org/10.1016/S0959-8049(18)30632-4

Metrics

8 Record Views

Details

Title: 466 (PB-099) - Prognostic impact of tumor fractions in plasma assessed with mFAST-SeqS on overall survival of metastatic breast cancer undergoing systemic treatment
Creators: C Suppan
I Brcic
E Heitzer
V Tiran
H.D Mueller
M Auer
R.J Cote
R Datar
N Dandachi
M Balic
Publication Details: European journal of cancer (1990), Vol.92, pp.S136-S136
Publisher: Elsevier Ltd
Academic Unit: Miller School of Medicine; UMMG Department of Pathology
Language: English
Resource Type: Journal article
Record Identifier: 991031599629002976